Evidence map›Paper›PMID 31586148›Full record

ArticleLeukemia2020

Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm.

Anna B Halpern, Nicholas P Howard, Megan Othus, Paul C Hendrie, Nikita V Baclig, Sarah A Buckley, Mary-Elizabeth M Percival, Pamela S Becker, Bart L Scott, Vivian G Oehler and 9 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Anna B HalpernDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Nicholas P HowardClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Megan OthusPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-8176-6371
Paul C HendrieDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Nikita V BacligDepartment of Medicine, Residency Program, University of Washington, Seattle, WA, USA.
Sarah A BuckleyClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Mary-Elizabeth M PercivalDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Pamela S BeckerDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-6235-9463
Bart L ScottClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Vivian G OehlerDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Terry B GernsheimerDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Siobán B KeelDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Johnnie J OrozcoClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ryan D CassadayDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Andrei R ShustovDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Garrett A HartleyPfizer Inc., New York, NY, USA.
Verna L WelchPfizer Inc., New York, NY, USA.
Elihu H EsteyDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Roland B WalterDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. rwalter@fredhutch.org.ORCID http://orcid.org/0000-0002-9268-3341
University of Washington · USFred Hutch Cancer Center · USPfizer (United States) · USUniversity of Washington Medical Center · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCytarabineFemaleHumansInduction ChemotherapyLeukemia, Myeloid, AcuteMaleMiddle AgedPatient DischargeYoung AdultCytarabine

Identifiers

PMID31586148
OpenAlexW2978944417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.